# FTIH Study With GSK958108

> **NCT00664365** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 21 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** GSK958108
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00664365
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-12
- **Primary completion:** 2008-08-22
- **Final completion:** 2008-08-22
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664365, "FTIH Study With GSK958108". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00664365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*